Lumos Diagnostics FY26 Financial Results
Key points
- Revenues from ordinary activities increased by 6.4% to US$13,192
- Loss from ordinary activities after tax decreased by 31.1% to US$4,952
- Loss for the year attributable to owners decreased by 31.1% to US$4,952
- Financial statements audited with an unmodified opinion, including material uncertainty over going concern
Full summary
Lumos Diagnostics Holdings Limited reported its preliminary final results for the year ended 30 June 2026, showing a 6.4% increase in revenues from ordinary activities to US$13,192. Despite this growth, the loss from ordinary activities after tax attributable to the owners of the company decreased by 31.1% to US$4,952. The overall loss for the year attributable to the owners also decreased by 31.1% to US$4,952. The financial statements have been audited, and an unmodified opinion has been issued, which includes a paragraph in respect of material uncertainty over the ability to continue as a going concern.
Sign in for more about this company, including guidance changes and other insights.
Sign in